?. Résultats, ????33 3.1 -Survie sans récidive ????????????????????, p.34

?. ???, 58 5.3 -Conclusion sur le bénéfice en termes de survie ?????, p.72

M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. Berger, Epidemiology of primary brain tumors: Current concepts and review of the literature, Neuro-Oncology, vol.4, issue.4, pp.278-299, 2002.
DOI : 10.1215/15228517-4-4-278

E. Ron, B. Modan, and J. Boice, Tumors of the Brain and Nervous System after Radiotherapy in Childhood, New England Journal of Medicine, vol.319, issue.16, pp.1033-1039, 1988.
DOI : 10.1056/NEJM198810203191601

A. Bricolo, S. Turazzi, and L. Cristofori, Experience in "radical" surgery of supratentorial gliomas in adults, J Neurosurg Sci, vol.34, pp.3-4297, 1990.

M. Lacroix, D. Abi-said, and D. Fourney, A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival, Journal of Neurosurgery, vol.95, issue.2, pp.190-198, 2001.
DOI : 10.3171/jns.2001.95.2.0190

R. Stupp, W. Mason, and M. Van-den-bent, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

W. Stummer, H. Stepp, and G. Möller, Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue, Acta Neurochirurgica, vol.140, issue.10, pp.995-1000, 1998.
DOI : 10.1007/s007010050206

W. Stummer, U. Pichlmeier, and T. Meinel, Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial, The Lancet Oncology, vol.7, issue.5, pp.392-401, 2006.
DOI : 10.1016/S1470-2045(06)70665-9

G. Sheline, The importance of distinguishing tumor grade in malignant gliomas: Treatment and prognosis, International Journal of Radiation Oncology*Biology*Physics, vol.1, issue.7-8, pp.781-786, 1976.
DOI : 10.1016/0360-3016(76)90166-8

O. Salazar, P. Rubin, M. Feldstein, and R. Pizzutiello, High dose radiation therapy in the treatment of malignant gliomas: Final Report, International Journal of Radiation Oncology*Biology*Physics, vol.5, issue.10, pp.1733-1740, 1979.
DOI : 10.1016/0360-3016(79)90554-6

N. Bleehen and S. Stenning, A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma, British Journal of Cancer, vol.64, issue.4, pp.769-774, 1991.
DOI : 10.1038/bjc.1991.396

W. Roa, P. Brasher, and G. Bauman, Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial, Journal of Clinical Oncology, vol.22, issue.9, pp.1583-1588, 2004.
DOI : 10.1200/JCO.2004.06.082

M. Walker, A. E. Hunt, and W. , Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas, Journal of Neurosurgery, vol.49, issue.3, pp.333-343, 1978.
DOI : 10.3171/jns.1978.49.3.0333

M. Deutsch, S. Green, and T. Strike, Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma, International Journal of Radiation Oncology*Biology*Physics, vol.16, issue.6, pp.1389-1396, 1989.
DOI : 10.1016/0360-3016(89)90939-5

W. Yung, L. Mechtler, and M. Gleason, Intravenous carboplatin for recurrent malignant glioma: a phase II study., Journal of Clinical Oncology, vol.9, issue.5, pp.860-864, 1991.
DOI : 10.1200/JCO.1991.9.5.860

W. Couldwell, D. Hinton, and A. Surnock, Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen, Clin. Cancer Res, vol.2, issue.4, pp.619-622, 1996.

J. Vredenburgh, A. Desjardins, and J. Herndon, Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme, Journal of Clinical Oncology, vol.25, issue.30, pp.4722-4729, 2007.
DOI : 10.1200/JCO.2007.12.2440

H. Friedman, M. Prados, and P. Wen, Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma, Journal of Clinical Oncology, vol.27, issue.28, pp.4733-4740, 2009.
DOI : 10.1200/JCO.2008.19.8721

I. Mellinghoff, M. Wang, and I. Vivanco, Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors, New England Journal of Medicine, vol.353, issue.19, pp.2012-2024, 2005.
DOI : 10.1056/NEJMoa051918

A. Brandes, E. Franceschi, A. Tosoni, M. Hegi, and R. Stupp, Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments, Clinical Cancer Research, vol.14, issue.4, pp.957-960, 2008.
DOI : 10.1158/1078-0432.CCR-07-1810

O. Bailey, Genesis of the Percival Bailey-Cushing Classification of Gliomas, Pediatric Neurosurgery, vol.12, issue.4-5, pp.4-5261, 1985.
DOI : 10.1159/000120262

K. Zülch, Principles of the new World Health Organization (WHO) classification of brain tumors, Neuroradiology, vol.22, issue.2, pp.59-66, 1980.
DOI : 10.1007/BF00342596

P. Kleihues, P. Burger, and B. Scheithauer, The New WHO Classification of Brain Tumours, Brain Pathology, vol.8, issue.3, pp.255-268, 1993.
DOI : 10.1002/1097-0142(19830801)52:3<550::AID-CNCR2820520327>3.0.CO;2-C

D. Louis, H. Ohgaki, and O. Wiestler, The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1007/s00401-007-0243-4

C. Daumas-duport and G. Szikla, [Definition of limits and 3D configuration of cerebral gliomas. Histological data, therapeutic incidences (author's transl)], Neurochirurgie, vol.27, issue.5, pp.273-284, 1981.

M. Mittler, B. Walters, and E. Stopa, Observer reliability in histological grading of astrocytoma stereotactic biopsies, Journal of Neurosurgery, vol.85, issue.6, pp.1091-1094, 1996.
DOI : 10.3171/jns.1996.85.6.1091

C. Daumas-duport, F. Beuvon, P. Varlet, and C. Fallet-bianco, [Gliomas: WHO and Sainte-Anne Hospital classifications], Ann Pathol, vol.20, issue.5, pp.413-428, 2000.

N. Abbott, A. Patabendige, D. Dolman, S. Yusof, and D. Begley, Structure and function of the blood???brain barrier, Neurobiology of Disease, vol.37, issue.1, pp.13-25, 2010.
DOI : 10.1016/j.nbd.2009.07.030

S. Schepartz, Early history and development of the nitrosoureas, Cancer Treat Rep, vol.60, issue.6, pp.647-649, 1976.

S. Fm, J. Tp, and G. Mccaleb, Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia, Cancer Res, vol.23, pp.725-733, 1963.

R. Weiss and B. Issell, The nitrosoureas: carmustine (BCNU) and lomustine (CCNU), Cancer Treatment Reviews, vol.9, issue.4, pp.313-330, 1982.
DOI : 10.1016/S0305-7372(82)80043-1

C. Chang, J. Horton, and D. Schoenfeld, Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study, Cancer, vol.2, issue.6, pp.997-1007, 1983.
DOI : 10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2

S. Green, D. Byar, and M. Walker, Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma, Cancer Treat Rep, vol.67, issue.2, pp.121-132, 1983.

R. Selker, W. Shapiro, and P. Burger, The Brain Tumor Cooperative Group NIH Trial 87-01: A Randomized Comparison of Surgery, External Radiotherapy, and Carmustine versus Surgery, Interstitial Radiotherapy Boost, External Radiation Therapy, and Carmustine, Neurosurgery, vol.51, issue.2, pp.343-355, 2002.
DOI : 10.1097/00006123-200208000-00009

L. Stewart, Chemotherapy in adult high-grade glioma: a systematic review and metaanalysis of individual patient data from 12 randomised trials, Lancet, vol.359, issue.9311, pp.1011-1018, 2002.

D. Vita, V. Carbone, P. Owens, and A. , Clinical trials with 1,3-bis(2-chloroethyl)-1- nitrosourea, NSC-409962, Cancer Res, vol.25, issue.11, pp.1876-1881, 1965.

D. Crittenden, B. Tranum, and A. Haut, Pulmonary Fibrosis after Prolonged Therapy with 1,3-Bis (2-chloroethyl)-nitrosourea, Chest, vol.72, issue.3, pp.372-373, 1977.
DOI : 10.1378/chest.72.3.372

J. Litam, D. Dail, and G. Spitzer, Early pulmonary toxicity after administration of highdose BCNU, Cancer Treat Rep, vol.65, issue.12, pp.39-44, 1981.

R. Cohen, P. Wiernik, and M. Walker, Acute nonlymphocytic leukemia associated with nitrosourea chemotherapy: report of two cases, Cancer Treat Rep, vol.60, issue.9, pp.1257-1261, 1976.

S. Michels, R. Mckenna, D. Arthur, and R. Brunning, Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases, Blood, vol.65, issue.6, pp.1364-1372, 1985.

V. Oliverio, Pharmacology of the nitrosoureas: an overview, Cancer Treat Rep, vol.60, issue.6, pp.703-707, 1976.

S. Grossman, R. C. Colvin, and O. , The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers, Journal of Neurosurgery, vol.76, issue.4, pp.640-647, 1992.
DOI : 10.3171/jns.1992.76.4.0640

A. Domb, M. Rock, and C. Perkin, Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain, Biomaterials, vol.16, issue.14, pp.1069-1072, 1995.
DOI : 10.1016/0142-9612(95)98902-Q

M. Wu, J. Tamada, H. Brem, and R. Langer, In vivo versusin vitro degradation of controlled release polymers for intracranial surgical therapy, Journal of Biomedical Materials Research, vol.17, issue.3, pp.387-395, 1994.
DOI : 10.1002/jbm.820280314

W. Dang, T. Daviau, and H. Brem, Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy, Pharmaceutical Research, vol.13, issue.5, pp.683-691, 1996.
DOI : 10.1023/A:1016035229961

R. Mirimanoff, T. Gorlia, and W. Mason, Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial, Journal of Clinical Oncology, vol.24, issue.16, pp.2563-2569, 2006.
DOI : 10.1200/JCO.2005.04.5963

F. Attenello, D. Mukherjee, and G. Datoo, Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience, Annals of Surgical Oncology, vol.45, issue.10, pp.2887-2893, 2008.
DOI : 10.1245/s10434-008-0048-2

M. Mcgirt, A. Villavicencio, K. Bulsara, H. Friedman, and A. Friedman, Management of tumor bed cysts after chemotherapeutic wafer implantation, Journal of Neurosurgery, vol.96, issue.5, pp.941-945, 2002.
DOI : 10.3171/jns.2002.96.5.0941

H. Bock, M. Puchner, and F. Lohmann, First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience, Neurosurgical Review, vol.148, issue.11, pp.441-449, 2010.
DOI : 10.1007/s10143-010-0280-7

B. Subach, T. Witham, and D. Kondziolka, Morbidity and survival after 1,3-bis(2- chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series, Neurosurgery, vol.45, issue.1, pp.17-22, 1999.

H. Brem, S. Piantadosi, and P. Burger, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas, The Lancet, vol.345, issue.8956, pp.1008-1012, 1995.
DOI : 10.1016/S0140-6736(95)90755-6

S. Valtonen, U. Timonen, and P. Toivanen, Interstitial Chemotherapy with Carmustine-loaded Polymers for High-grade Gliomas: A Randomized Double-blind Study, Neurosurgery, vol.41, issue.1, pp.44-48, 1997.
DOI : 10.1097/00006123-199707000-00011

M. Westphal, D. Hilt, and E. Bortey, A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma, Neuro-Oncology, vol.5, issue.2, pp.79-88, 2003.
DOI : 10.1093/neuonc/5.2.79

M. Westphal, R. Z. Riddle, V. Hilt, D. Bortey, and E. , Gliadel?? wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial, Acta Neurochirurgica, vol.5, issue.[Suppl] 1, pp.269-275, 2006.
DOI : 10.1007/s00701-005-0707-z

H. Brem, R. Tamargo, and A. Olivi, Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain, Journal of Neurosurgery, vol.80, issue.2, pp.283-290, 1994.
DOI : 10.3171/jns.1994.80.2.0283

M. Yang, R. Tamargo, and H. Brem, Controlled delivery of 1,3-bis(2-chloroethyl)-1- nitrosourea from ethylene-vinyl acetate copolymer, Cancer Res, vol.49, issue.18, pp.5103-5107, 1989.

R. Tamargo, J. Myseros, and J. Epstein, Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain, Cancer Res, vol.53, issue.2, pp.329-333, 1993.

M. Mcgirt, K. Than, and J. Weingart, Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme, Journal of Neurosurgery, vol.110, issue.3, pp.583-588, 2009.
DOI : 10.3171/2008.5.17557

M. Affronti, C. Heery, and J. Herndon, Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy, Cancer, vol.3, issue.15, pp.3501-3511, 2009.
DOI : 10.1002/cncr.24398

W. Curran, C. Scott, and J. Horton, Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials, JNCI Journal of the National Cancer Institute, vol.85, issue.9, pp.704-710, 1993.
DOI : 10.1093/jnci/85.9.704

S. Wellek and A. Ziegler, Cochran-Armitage Test versus Logistic Regression in the Analysis of Genetic Association Studies, Human Heredity, vol.73, issue.1, pp.14-17, 2012.
DOI : 10.1159/000334085

A. Giese, T. Kucinski, and U. Knopp, Pattern of Recurrence following Local Chemotherapy with Biodegradable Carmustine (BCNU) Implants in Patients with Glioblastoma, Journal of Neuro-Oncology, vol.66, issue.3, pp.351-360, 2004.
DOI : 10.1023/B:NEON.0000014539.90077.db

P. Menei, P. Metellus, and E. Parot-schinkel, Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience, Annals of Surgical Oncology, vol.13, issue.4, pp.1740-1746, 2010.
DOI : 10.1245/s10434-010-1081-5

G. Noël, R. Schott, and S. Froelich, Retrospective Comparison of Chemoradiotherapy Followed by Adjuvant Chemotherapy, With or Without Prior Gliadel Implantation (Carmustine) After Initial Surgery in Patients With Newly Diagnosed High-Grade Gliomas, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.749-755, 2012.
DOI : 10.1016/j.ijrobp.2010.11.073

E. Weber and E. Goebel, Cerebral edema associated with Gliadel wafers: Two case studies, Neuro-Oncology, vol.7, issue.1, pp.84-89, 2005.
DOI : 10.1215/S1152851704000614

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1871626

L. Dörner, S. Ulmer, A. Rohr, H. Mehdorn, and A. Nabavi, Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel?? implantation ??? incidence, therapeutic strategies, and outcome, Journal of Clinical Neuroscience, vol.18, issue.3, pp.347-351, 2011.
DOI : 10.1016/j.jocn.2010.05.036

M. Smith, J. Thompson, and M. Castillo, MR of recurrent high-grade astrocytomas after intralesional immunotherapy, AJNR Am J Neuroradiol, vol.17, issue.6, pp.1065-1071, 1996.

J. Gallego, J. Barcia, and C. Barcia-mariño, Fatal outcome related to carmustine implants in glioblastoma multiforme, Acta Neurochirurgica, vol.17, issue.4, pp.261-265, 2007.
DOI : 10.1007/s00701-006-1097-6

A. Puppa, M. Rossetto, and P. Ciccarino, Carmustine Wafer Implantation When Surgical Cavity Is Communicating with Cerebral Ventricles: Technical Considerations on a Clinical Series, World Neurosurgery, vol.76, issue.1-2, pp.156-159, 2011.
DOI : 10.1016/j.wneu.2010.10.024

G. Blomstedt, Craniotomy infections, Neurosurg. Clin. N. Am, vol.3, issue.2, pp.375-385, 1992.

E. Brown, Antimicrobial prophylaxis in neurosurgery, Journal of Antimicrobial Chemotherapy, vol.31, issue.suppl B, p.31, 1993.
DOI : 10.1093/jac/31.suppl_B.49

P. Mcgovern, E. Lautenbach, P. Brennan, R. Lustig, and N. Fishman, Risk Factors for Postcraniotomy Surgical Site Infection after 1,3???Bis (2???Chloroethyl)???1???Nitrosourea (Gliadel) Wafer Placement, Clinical Infectious Diseases, vol.36, issue.6, pp.759-765, 2003.
DOI : 10.1086/368082

H. Muntasser, I. Liaquat, A. Barlow, and I. Whittle, Gliadel wafers acting as a lattice for bacterial growth: a case illustration, Acta Neurochirurgica, vol.2, issue.10, pp.2099-2100, 2011.
DOI : 10.1007/s00701-011-1087-1

S. Limentani, A. Asher, M. Heafner, J. Kim, and R. Fraser, A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme, Journal of Neuro-Oncology, vol.3, issue.3, pp.241-244, 2005.
DOI : 10.1007/s11060-004-2339-1

R. Jain and L. Baxter, Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure, Cancer Res, vol.4824, issue.1, pp.7022-7032, 1988.

Y. Boucher, H. Salehi, B. Witwer, G. Harsh, and R. Jain, Interstitial fluid pressure in intracranial tumours in patients and in rodents, British Journal of Cancer, vol.75, issue.6, pp.829-836, 1997.
DOI : 10.1038/bjc.1997.148

L. Baxter and R. Jain, Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection, Microvascular Research, vol.37, issue.1, pp.77-104, 1989.
DOI : 10.1016/0026-2862(89)90074-5

L. Gerlowski and R. Jain, Microvascular permeability of normal and neoplastic tissues, Microvascular Research, vol.31, issue.3, pp.288-305, 1986.
DOI : 10.1016/0026-2862(86)90018-X

R. Blasberg, C. Patlak, and J. Fenstermacher, Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion, J. Pharmacol. Exp. Ther, vol.195, issue.1, pp.73-83, 1975.

C. Wang, J. Li, C. Teo, and T. Lee, The delivery of BCNU to brain tumors, Journal of Controlled Release, vol.61, issue.1-2, pp.21-41, 1999.
DOI : 10.1016/S0168-3659(99)00098-X

V. Oliverio, Pharmacology of the nitrosoureas: an overview, Cancer Treat Rep, vol.60, issue.6, pp.703-707, 1976.

R. Bobo, D. Laske, and A. Akbasak, Convection-enhanced delivery of macromolecules in the brain., Proceedings of the National Academy of Sciences, vol.91, issue.6, pp.2076-2080, 1994.
DOI : 10.1073/pnas.91.6.2076

P. Morrison, M. Chen, R. Chadwick, R. Lonser, and E. Oldfield, Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics, Am. J. Physiol, vol.277, issue.4 2, pp.1218-1229, 1999.

R. Saito, J. Bringas, and T. Mcknight, Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging, Cancer Research, vol.64, issue.7, pp.2572-2579, 2004.
DOI : 10.1158/0008-5472.CAN-03-3631

R. Saito, J. Bringas, and A. Panner, Convection-Enhanced Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand with Systemic Administration of Temozolomide Prolongs Survival in an Intracranial Glioblastoma Xenograft Model, Cancer Research, vol.64, issue.19, pp.6858-6862, 2004.
DOI : 10.1158/0008-5472.CAN-04-1683

M. Chen, R. Lonser, P. Morrison, L. Governale, and E. Oldfield, Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue???cannula sealing time, Journal of Neurosurgery, vol.90, issue.2, pp.315-320, 1999.
DOI : 10.3171/jns.1999.90.2.0315

A. Giese and M. Westphal, Glioma Invasion in the Central Nervous System, Neurosurgery, vol.39, issue.2, pp.235-250, 1996.
DOI : 10.1097/00006123-199608000-00001